Navigation Links
Zemea Propanediol Meets U.S. Environmental Protection Agency Design for the Environment Criteria
Date:12/30/2008

DuPont today announced that the breakthrough bio-based ingredient, Zemea® propanediol, has been independently evaluated by NSF International and now is listed in the CleanGredients® database as passing the U.S. Environmental Protection Agency (EPA) Design for the Environment (DfE) screen. Zemea® is produced and marketed by the DuPont Tate & Lyle Bio Products joint venture.

Loudon, TN (Vocus) December 30, 2008 -- DuPont today announced that the breakthrough bio-based ingredient, Zemea® propanediol, has been independently evaluated by NSF International and now is listed in the CleanGredients® database as passing the U.S. Environmental Protection Agency (EPA) Design for the Environment (DfE) screen. Zemea® is produced and marketed by the DuPont Tate & Lyle Bio Products joint venture.

Zemea® is the first DfE-screened solvent to be listed in CleanGredients®. It is a 100 percent natural ingredient made from corn sugar and developed for use in the cleaning and personal care categories. Zemea® is a sustainable alternative to petroleum-based glycols in cleaning product formulations where the product's solvency properties, purity level, low irritation and excellent moisturization properties are benefits.
   
CleanGredients® is an online database of quality cleaning product ingredients. It helps formulators identify the ingredients they need to help them formulate greener, more sustainable cleaning products. CleanGredients® is a project of nonprofit institute GreenBlue®.

"We're excited to be the first solvent listed in CleanGredients®," said David Wood, product director -- DuPont Tate & Lyle Bio Products. "We share similar objectives with GreenBlue® around quality, sustainability and minimizing our environmental footprint. We believe this listing will enable more formulators to take advantage of the performance benefits of Zemea® and help them to streamline the process for achieving DfE recognition for their cleaning products."

DfE is one of the EPA's premier partnership programs, working with industry sectors to compare and improve the human health and environmental risks - as well as the performance and cost - of existing and alternative products, processes and practices. The DfE provides screens for safer chemicals to identify preferred ingredients. NSF International provides third party reviews for the U.S. EPA DfE formulator program. NSF International is the world leader in standards development, product certification, education and risk-management for public health and safety.
   
DuPont Tate & Lyle Bio Products is a joint venture between DuPont, a global science company, and Tate & Lyle, a world-leading renewable food and industrial ingredients company. DuPont Tate & Lyle Bio Products provides natural and renewably sourced ingredients that do not compromise product performance. For more information on the company's products, visit www.duponttateandlyle.com.

DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

The DuPont Oval Logo, DuPont™, The miracles of science™, and Bio-PDO™ are registered trademarks or trademarks of DuPont or its affiliates.

Zemea® is a registered trademark of DuPont Tate & Lyle Bio Products LLC.

CleanGredients® is a registered trademark of GreenBlue.

GreenBlue® is a registered trademark of GreenBlue.

###

Read the full story at http://www.prweb.com/releases/DuPont/Zemea_propanediol/prweb1807494.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Zemea Propanediol Approved as a Natural Ingredient by ECOCERT
2. Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery
3. Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C
4. Serica Technologies Receives ISO Certification, Meets International Standards for Medical Device Manufacturing
5. EntreMeds MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial
6. VNUS Medical Technologies, Inc. Announces the Hiring of Guido Smeets, MD, as Vice President of Clinical Research and Chief Medical Officer
7. Asenapine Meets Primary Endpoint in Long-Term Schizophrenia Relapse Prevention Trial
8. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
9. Teliks Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
10. The Science of Music Meets the Art of Medicine - ARIMM 3rd Annual Conference at IPFW, September 12-13, 2008
11. Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Zemea Propanediol Meets U.S. Environmental Protection Agency Design for the Environment Criteria
(Date:12/8/2016)... Dec. 8, 2016  Anaconda BioMed S.L., a pre-clinical ... the next generation neuro-thrombectomy system for the treatment of ... G. Jovin, MD to join its Scientific Advisory Board ... strategic network of scientific and clinical experts to Anaconda ... the ANCD BRAIN ® to its clinical phase. ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... their exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. This ... products engineered to radically streamline culture processes, minimize processing time, significantly decrease ...
(Date:12/8/2016)... Ames, Iowa (PRWEB) , ... December 08, 2016 , ... ... of asynchronous approvals for biotech crops. The authors focus on the economic effects in ... the global approval of new biotech crops and the resultant risk of low level ...
(Date:12/8/2016)... -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), ... products to treat rare diseases where there is an ... hosting an Investor Webcast Event Friday, December 16, 2016, ... defense regulators (IDRs) as a new drug class, as ... recently announced and published Phase 2 clinical data for ...
Breaking Biology Technology:
(Date:11/29/2016)... , Nov. 29, 2016   ... identification and object recognition technologies, today released ... for fingerprint recognition solutions that run on ... fingerprint template using less than 128KB of ... compact devices that have limited on-board resources, ...
(Date:11/28/2016)... 2016 "The biometric system ... The biometric system market is in the growth ... near future. The biometric system market is expected to ... a CAGR of 16.79% between 2016 and 2022. Government ... technology in smartphones, rising use of biometric technology in ...
(Date:11/22/2016)... 2016 According to the new market research report ... Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), ... market is expected to grow from USD 10.74 Billion in 2015 to ... 2016 and 2022. Continue Reading ... ...
Breaking Biology News(10 mins):